|
π
|
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer.
11 auth.
R. Kim,
V. Chung,
O. Alese,
B. El-Rayes,
Daneng Li,
T. Al-Toubah,
...
M. Schell,
Jun-min Zhou,
A. Mahipal,
B. Kim,
Dae Won Kim
|
8 |
2020 |
8
π
|
|
π
|
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
15 auth.
Namrata Vijayvergia,
A. Dasari,
M. Deng,
S. Litwin,
T. Al-Toubah,
R. Alpaugh,
E. Dotan,
M. Hall,
Nicole M. Ross,
Melissa M. Runyen,
...
C. Denlinger,
D. Halperin,
S. Cohen,
P. Engstrom,
J. Strosberg
|
6 |
2020 |
6
π
|
|
π¬
|
177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
Satya N. Das,
T. Al-Toubah,
G. El-Haddad,
J. Strosberg
|
6 |
2019 |
6
π¬
|
|
π¦
|
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms.
T. Al-Toubah,
B. Morse,
J. Strosberg
|
5 |
2019 |
5
π¦
|
|
π
|
Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy
8 auth.
J. Strosberg,
T. Al-Toubah,
E. Pelleβ,
Johnna Smith,
M. Haider,
Tai Hutchinson,
...
J. Fleming,
G. El-Haddad
|
5 |
2020 |
5
π
|
|
π¦
|
Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms.
T. Al-Toubah,
E. Pelleβ,
T. Valone,
M. Haider,
J. Strosberg
|
5 |
2021 |
5
π¦
|
|
π¦
|
Novel immunotherapy strategies for treatment of neuroendocrine neoplasms.
T. Al-Toubah,
M. Cives,
J. Strosberg
|
4 |
2020 |
4
π¦
|
|
π
|
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers
7 auth.
E. Tan,
B. Cao,
Jongphil Kim,
T. Al-Toubah,
R. Mehta,
B. Centeno,
...
R. Kim
|
4 |
2020 |
4
π
|
|
π
|
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When KI-67 is β₯10%?
17 auth.
E. Merola,
T. Alonso Gordoa,
Panpan Zhang,
T. Al-Toubah,
E. Pelleβ,
A. KolasiΕska-ΔwikΕa,
W. Zandee,
F. Laskaratos,
L. Mestier,
A. Lamarca,
...
J. Hernando,
J. CwikΕa,
J. Strosberg,
W. Herder,
M. Caplin,
M. Cives,
R. Leeuwaarde
|
4 |
2020 |
4
π
|
